FDA Inspection 1021832 — CSL Plasma Inc.
The FDA completed an inspection of CSL Plasma Inc. on July 12, 2017 in South Milwaukee, WI. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 12, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- South Milwaukee, WI (United States)